SARS-CoV-2与慢性HBV共感染患者的肝功能特征
研究纳入2020年2月1日至29日同济医院105例SARS-CoV-2与慢性HBV共感染成人患者,描述肝功能特征及其与疾病严重度和预后的关联。入院时部分患者肝酶和胆红素升高,住院期间上述指标显著上升;14例(13.33%)发生肝损伤,其中4例(28.57%)进展为慢加急性肝衰竭,肝损伤患者重症比例和死亡率更高。
要点
- 105例共感染患者中14例(13.33%)发生肝损伤,10例(71.43%)在8天(范围6-21天)内恢复。
- 肝损伤患者中4例(28.57%)快速进展为慢加急性肝衰竭。
- 肝损伤患者死亡率28.57% vs 无肝损伤患者3.30%(P = .004)。
核心结论
- SARS-CoV-2与慢性HBV共感染患者的肝损伤与疾病严重度和不良预后相关。
- 在慢性HBV感染患者COVID-19治疗期间,应重视并频繁评估肝功能。
研究设计与样本
- 研究纳入2020年2月1日至2月29日于同济医院住院的所有成人SARS-CoV-2与慢性HBV共感染患者,共105例。
- 收集人口学、临床特征、实验室检查、治疗和临床结局数据,描述肝功能特征及其与疾病严重度和预后的关联。
主要发现
- 入院时丙氨酸氨基转移酶升高22例(20.95%),天冬氨酸氨基转移酶升高29例(27.62%),总胆红素升高7例(6.67%),γ-谷氨酰转移酶升高7例(6.67%),碱性磷酸酶升高1例(0.95%)。
- 住院期间上述指标水平显著上升(均P < .05)。
- 14例(13.33%)发生肝损伤,其中10例(71.43%)在8天(范围6-21天)后恢复,4例(28.57%)快速进展为慢加急性肝衰竭。
- 肝损伤患者中重症COVID-19比例更高(P = .042);慢加急性肝衰竭、急性心脏损伤和休克等并发症在肝损伤患者中更常见(均P < .05)。
- 肝损伤患者死亡率28.57% vs 无肝损伤患者3.30%(P = .004)。
临床怎么用
- 在慢性HBV感染患者COVID-19治疗期间,应重视并频繁评估肝功能。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Coronavirus disease 2019 (COVID-19) is a major global health threat. We aimed to describe the characteristics of liver function in patients with SARS-CoV-2 and chronic hepatitis B virus (HBV) coinfection. METHODS: We enrolled all adult patients with SARS-CoV-2 and chronic HBV coinfection admitted to Tongji Hospital from February 1 to February 29, 2020. Data of demographic, clinical characteristics, laboratory tests, treatments, and clinical outcomes were collected. The characteristics of liver function and its association with the severity and prognosis of disease were described. RESULTS: Of the 105 patients with SARS-CoV-2 and chronic HBV coinfection, elevated levels of liver test were observed in several patients at admission, including elevated levels of alanine aminotransferase (22, 20.95%), aspartate aminotransferase (29, 27.62%), total bilirubin (7, 6.67%), gamma-glutamyl transferase (7, 6.67%), and alkaline phosphatase (1, 0.95%). The levels of the indicators mentioned above increased substantially during hospitalization (all P < .05). Fourteen (13.33%) patients developed liver injury. Most of them (10, 71.43%) recovered after 8 (range 6-21) days. Notably the other, 4 (28.57%) patients rapidly progressed to acute-on-chronic liver failure. The proportion of severe COVID-19 was higher in patients with liver injury (P = .042). Complications including acute-on-chronic liver failure, acute cardiac injury and shock happened more frequently in patients with liver injury (all P < .05). The mortality was higher in individuals with liver injury (28.57% vs 3.30%, P = .004). CONCLUSION: Liver injury in patients with SARS-CoV-2 and chronic HBV coinfection was associated with severity and poor prognosis of disease. During the treatment of COVID-19 in chronic HBV-infected patients, liver function should be taken seriously and evaluated frequently.
引用
- Zou X, Fang M, Li S, et al. Characteristics of Liver Function in Patients With SARS-CoV-2 and Chronic HBV Coinfection. Clin Gastroenterol Hepatol. 2020. PMID: 32553907. doi:10.1016/j.cgh.2020.06.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。